Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
|3||Enrolling by invitation||
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)
|4||Enrolling by invitation||
Long-Term Sulfonylurea Response in KCNJ11 Neonatal Diabetes
† Study has passed its completion date and status has not been verified in more than two years.